Titre:
  • Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial
Auteur:Kalakonda, Nagesh; Maerevoet, Marie; Cavallo, Federica; Follows, George; Goy, Andre; Vermaat, Joost J.S.P.; Casasnovas, Olivier; Hamad, Nada; Zijlstra, Josée J.M.; Bakhshi, Sameer; Bouabdallah, Reda; Choquet, Sylvain; Gurion, Ronit; Hill, Brian; Jaeger, Ulrich; Sancho, Juan Manuel; Schuster, Michael; Thieblemont, Catherine; De la Cruz, Fátima; Egyed, Miklos; Mishra, Sourav; Offner, Fritz; Vassilakopoulos, Theodoros; Warzocha, Krzysztof; McCarthy, Daniel; Ma, Xiwen; Corona, Kelly; Saint-Martin, Jean-Richard; Chang, Hua; Landesman, Yosef; Joshi, Anita; Wang, Hongwei; Shah, Jatin; Shacham, Sharon; Kauffman, Michael; Van Den Neste, Eric; Canales, Miguel Ángel M.A.
Informations sur la publication:The Lancet Haematology, 7, 7, page (e511-e522)
Statut de publication:Publié, 2020-07
Sujet CREF:Généralités
Note générale:SCOPUS: ar.j
DecretOANoAutActif
Langue:Anglais
Identificateurs:urn:issn:2352-3026
info:doi/10.1016/S2352-3026(20)30120-4
info:pii/S2352302620301204
info:scp/85086735506